Loading company…
PreemptiveAI uses machine learning and device data to predict health outcomes.
PreemptiveAI analyzes biomedical signals from smartphones and wearable devices to map physiology and pathology. Its foundation model can be adapted for different health applications. Founded in 2022 and based in Seattle, US, it raised USD 6.4 million in venture funding in March 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in